Lysergic Acid Diethylamide is named as an intervention in 2 current clinical trials in our Switzerland register. 1 is recruiting patients now. The most common phase is Observational. The sponsor with the most trials is University Hospital, Geneva (1). The most-studied condition is Major Depressive Disorder (MDD).
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Lysergic Acid Diethylamide (LSD) as Treatment for Cluster Headache
NCT03781128 · ClinicalTrials.gov ↗ · Cluster Headache
|
Phase 2 | Recruiting | University Hospital, Basel, Switzerland | Switzerland |
|
Retrospective Observational Study of Intensity Effects in Psychedelic-assisted Treatment
NCT07164287 · ClinicalTrials.gov ↗ · Major Depressive Disorder (MDD), Anxiety Disorders, Substance Use Disorder (SUD)
|
Observational | Active, closed | University Hospital, Geneva | Switzerland |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Lead sponsor | Trials |
|---|---|
| University Hospital, Geneva | 1 |
| University Hospital, Basel, Switzerland | 1 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Switzerland | 2 | 1 |
A trial with sites in more than one country appears in each of those registers.
2 current trials in our Switzerland register name Lysergic Acid Diethylamide as a drug or biological intervention, as of the registry sync on 28 September 2026. Completed and withdrawn studies are not counted.
Yes. 1 of the 2 trials is recruiting: 1 with sites in Switzerland. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
University Hospital, Geneva (1) and University Hospital, Basel, Switzerland (1). The number in brackets is how many trials each organisation leads.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Lysergic Acid Diethylamide works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Lysergic Acid Diethylamide works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Lysergic Acid Diethylamide (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 28 Sep 2026.